title: Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice.
abstract: Mortality related to bacteremic pneumonia remains high, and the role of sepsis in inflammation, pulmonary injury, and death remains unclear, mostly in leukopenic states. In the present study, the microbiology, histopathology, and host response to Streptococcus pneumoniae and Klebsiella pneumoniae infection were determined in an experimental model of bacteremia in immunocompetent and leukopenic mice. Leukocyte depletion by cyclophosphamide did not impair the early clearance of pneumococci from blood but facilitated growth in lungs. By contrast, klebsiellae rapidly grew in blood of leukopenic mice. These observations suggest that tissue-based phagocytes and circulating leukocytes, respectively, play prominent roles in S. pneumoniae and K. pneumoniae eradication. The kinetics of leukocyte recruitment in lungs during S. pneumoniae bacteremia suggested early strong inflammation in immunocompetent mice that is associated with tumor necrosis factor alpha release and histological disorders, including cell debris and surfactant in alveolar spaces. Leukocyte depletion further stimulated pulmonary capillary leakage both in S. pneumoniae and K. pneumoniae bacteremia, which seemed attributable to bacterial virulence factors. Nitric oxide production did not differ significantly among groups. Leukopenia and low platelet counts characterized the late stage of bacteremia for both strains, but only K. pneumoniae altered renal function. Understanding the pathogenesis of bacteremia will help establish beneficial therapies for both sepsis and pneumonia.
authors.affiliation: Centre de Recherche en Infectiologie, Université Laval, Québec, Québec, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Wang
authors.forename: N
authors.initials: N
authors.lastname: Ouellet
authors.forename: M
authors.initials: M
authors.lastname: Simard
authors.forename: I
authors.initials: I
authors.lastname: Fillion
authors.forename: Y
authors.initials: Y
authors.lastname: Bergeron
authors.forename: D
authors.initials: D
authors.lastname: Beauchamp
authors.forename: M G
authors.initials: MG
authors.lastname: Bergeron
mesh_terms: D000818:Animals; D016470:Bacteremia / Q000276:immunology / Q000382:microbiology / Q000503:physiopathology*; D001769:Blood / Q000382:microbiology; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D006403:Hematologic Tests; D007121:Immunocompetence; D018836:Inflammation Mediators / Q000378:metabolism; D007710:Klebsiella Infections / Q000276:immunology / Q000382:microbiology / Q000503:physiopathology*; D007711:Klebsiella pneumoniae / Q000254:growth & development / Q000276:immunology*; D007958:Leukocyte Count; D007970:Leukopenia; D008168:Lung / Q000098:blood supply / Q000382:microbiology / Q000473:pathology; D051379:Mice; D011008:Pneumococcal Infections / Q000276:immunology / Q000382:microbiology / Q000503:physiopathology*; D013296:Streptococcus pneumoniae / Q000254:growth & development / Q000276:immunology*
chemical_list: D018836:Inflammation Mediators